Introduction 7.5032105
: 2.7003784
Ċ 1.1506985
British 14.953908
Ġbi 9.830096
otechnology 2.0448172
Ġcompany 0.46417522
ĠXY 12.1710005
Z 4.0578737
Ġhas 2.4838905
Ġannounced 4.6267734
Ġencouraging 9.289171
Ġfindings 5.0383916
Ġfrom 0.610548
Ġthe 2.7822804
Ġfinal 4.550889
Ġstage 1.6151652
Ġof 0.21527925
Ġclinical 1.1539792
Ġtrials 0.107602574
Ġfor 0.7466211
Ġits 1.2974106
Ġgroundbreaking 5.479266
Ġcancer 3.1059277
Ġdrug 1.3390237
. 1.1459697
ĠThe 1.3707749
Ġdrug 1.1035647
, 0.7548803
Ġcod 2.5338953
en 0.009933249
amed 0.00029676838
ĠT 4.581516
um 4.8027277
oro 7.837771
C 4.1438503
ure 5.1242347
, 0.29410234
Ġhas 1.0583122
Ġdemonstrated 4.030315
Ġsignificant 3.1683428
Ġefficacy 1.7585915
Ġand 4.215869
Ġa 2.1734579
Ġfavorable 4.537735
Ġsafety 0.38796234
Ġprofile 0.023701765
Ġin 0.41780847
Ġtreating 2.577796
Ġvarious 3.7967308
Ġtypes 1.3392417
Ġof 0.0055887233
Ġcancer 0.89824283
. 0.68468577
ĠHowever 4.276224
, 0.027608773
Ġwhile 4.640839
Ġthe 0.97838753
Ġnews 4.4041467
Ġhas 1.203908
Ġgenerated 3.9448707
Ġexcitement 1.3779165
Ġand 2.453111
Ġhope 3.1945004
Ġamong 1.6005342
Ġpatients 0.8836109
, 1.4063658
Ġanalysts 4.86614
Ġare 2.2449965
Ġadvising 4.9932675
Ġa 2.3238595
Ġmeasured 4.0876427
Ġapproach 1.8383111
Ġwhen 5.954426
Ġevaluating 2.0749435
Ġthe 0.20039125
Ġpotential 2.669037
Ġmarket 2.1731496
Ġimpact 1.370323
Ġand 3.2224083
Ġlong 3.3388424
- 0.18770549
term 0.010457185
Ġviability 1.8445972
Ġof 0.025488466
Ġthe 0.3116617
Ġdrug 0.58811677
. 0.12035157
Ċ 0.5699283
Pos 8.183557
itive 0.00070830766
Ġresults 2.8074389
Ġfrom 0.8202337
Ġclinical 2.3572173
Ġtrials 0.16438012
: 3.1783144
Ċ 0.06733183
T 2.1139255
um 0.009355078
oro 0.008153228
C 0.0006913669
ure 0.00036503928
's 3.8708591
Ġpositive 2.9547281
Ġoutcomes 4.7300563
Ġstem 3.5467925
Ġfrom 0.061667465
Ġcomprehensive 8.049522
ĠPhase 2.399258
ĠIII 0.28974327
Ġclinical 0.7484687
Ġtrials 0.058390364
, 1.7524623
Ġconducted 3.670791
Ġon 1.8564411
Ġa 1.9715759
Ġlarge 2.754787
Ġcohort 2.398869
Ġof 0.035476886
Ġpatients 0.6286499
Ġacross 2.9525735
Ġdifferent 4.1088767
Ġcancer 0.9492138
Ġtypes 0.2018201
. 0.3231174
ĠThe 0.9899933
Ġdrug 1.3767585
Ġexhibited 4.4107165
Ġremarkable 4.7922244
Ġtumor 5.007618
Ġregression 1.9740449
Ġrates 1.0652512
, 1.505868
Ġshowing 6.1578355
Ġpromise 3.2792802
Ġas 1.2776138
Ġa 0.2918343
Ġpotential 2.0825582
Ġbreakthrough 3.5259392
Ġin 1.307727
Ġcancer 0.9928261
Ġtreatment 0.2988076
. 0.09479418
ĠWith 5.4132404
Ġits 3.9959939
Ġunique 4.285734
Ġmechanism 0.62186784
Ġof 0.055414192
Ġaction 0.045120705
Ġtargeting 3.8848045
Ġspecific 3.4401538
Ġcancer 0.9033908
Ġmarkers 3.9934556
, 0.21548145
ĠT 0.44075197
um 0.00050791225
oro 0.0013113399
C 0.0007531019
ure 0.0038384167
Ġoffers 3.8961587
Ġa 0.83653617
Ġnovel 3.101857
Ġapproach 1.3074412
, 5.2368097
Ġdifferent 4.107147
iating 1.2867104
Ġit 0.41277695
Ġfrom 0.017650275
Ġconventional 2.6071503
Ġtherapies 2.6148248
Ġcommonly 8.012938
Ġused 0.24610704
Ġtoday 0.87926984
. 0.09744647
Ċ 0.7889874
E 6.391514
ffic 1.1951067
acy 0.011947578
Ġand 1.0273706
Ġsafety 0.1738933
Ġprofile 2.0178566
: 0.30798778
Ċ 0.039961237
Not 5.991489
ably 0.7609449
, 0.0061890106
ĠT 0.6717393
um 0.0004941948
oro 0.0010706062
C 0.0006723386
ure 0.00014265596
Ġdemonstrated 2.1730258
Ġefficacy 3.1942124
Ġacross 1.0889386
Ġa 1.1638964
Ġwide 0.95253277
Ġrange 0.5274082
Ġof 0.0026555327
Ġcancer 0.54454666
Ġtypes 0.061183613
, 0.44671756
Ġincluding 0.50619334
Ġbreast 0.9666895
, 0.2503345
Ġlung 1.0644006
, 0.12024649
Ġpancreat 2.9090378
ic 3.583558e-05
, 0.24064645
Ġand 0.9146329
Ġcol 1.3436012
ore 0.0018970624
ct 4.9782993e-05
al 0.0006299322
Ġcancer 1.3592452
. 0.2513519
ĠScientific 10.882692
Ġevidence 3.5913208
Ġhighlights 6.2803974
Ġthe 0.84479034
Ġdrug 0.70531994
's 0.030305216
Ġability 1.6273485
Ġto 0.006433857
Ġinhibit 3.0181906
Ġcancer 1.4018497
Ġcell 0.99651366
Ġproliferation 1.0181303
Ġand 1.0224549
Ġinduce 0.88491005
Ġapopt 0.7033795
osis 0.018164186
Ġthrough 3.9650314
Ġa 1.8079206
Ġseries 4.2450657
Ġof 0.00081728684
Ġwell 4.440872
- 0.023929384
defined 1.0966206
Ġbiological 3.4394524
Ġpathways 0.66226506
. 0.16016692
ĠMoreover 3.1744614
, 0.00081919605
Ġthe 1.11564
Ġside 5.636141
Ġeffects 0.9733868
Ġobserved 2.2337835
Ġwere 1.6720419
Ġrelatively 2.4601235
Ġmild 0.5328491
, 0.6875795
Ġpresenting 5.1406074
Ġa 1.716439
Ġless 6.481216
Ġburdens 3.3860786
ome 4.7041198e-05
Ġtreatment 0.8706592
Ġoption 1.8876221
Ġcompared 2.6899748
Ġto 0.13347495
Ġcurrent 2.331856
Ġavailable 4.595526
Ġalternatives 4.8050046
. 0.05058002
Ċ 0.37855434
Analy 3.9862485
sts 0.049977362
Ġremain 3.9447658
Ġcautious 0.38907188
: 0.19853315
Ċ 0.015364139
While 1.4989382
Ġthe 0.88075376
Ġresults 2.1298048
Ġare 0.98605186
Ġundoubtedly 2.7141495
Ġpromising 1.3696716
, 0.09055681
Ġanalysts 0.938206
Ġcaution 3.0935862
Ġagainst 0.9482463
Ġoverly 4.3403287
Ġoptimistic 0.211691
Ġexpectations 1.6812574
Ġat 4.3773084
Ġthis 0.06614558
Ġearly 1.5418147
Ġstage 0.09118513
. 0.1985786
ĠExperts 6.2563367
Ġemphasize 3.7518535
Ġthe 0.487244
Ġneed 0.62216765
Ġfor 0.5589024
Ġadditional 2.7082887
Ġscrutiny 5.963568
Ġand 1.4008722
Ġfurther 2.8728213
Ġvalidation 2.2375982
Ġin 3.0837839
Ġlarger 1.7921004
, 1.4392488
Ġmore 0.87514204
Ġdiverse 0.3312688
Ġpatient 0.63204205
Ġpopulations 0.8361787
Ġto 2.5641303
Ġdetermine 2.887642
Ġthe 0.4664721
Ġapplic 5.9092326
ability 8.018216e-05
Ġand 1.2564081
Ġmarket 3.9374464
Ġpotential 0.50995374
Ġof 0.13893642
ĠT 0.699493
um 0.0009789
oro 0.0011380952
C 0.0004434504
ure 0.00025431695
. 0.13181888
ĠTrials 10.280635
Ġoften 8.228994
Ġface 3.0696278
Ġunforeseen 3.9913044
Ġchallenges 0.8712333
Ġwhen 3.939853
Ġtransitioning 2.3306088
Ġto 1.8224267
Ġreal 3.273047
- 0.15810905
world 0.12155373
Ġsettings 1.2786406
, 0.28866047
Ġhighlighting 4.413666
Ġthe 0.048538525
Ġimportance 1.0092885
Ġof 0.01915538
Ġrigorous 4.1550746
Ġpost 2.3085418
- 0.034702007
market 0.49202043
ing 1.4652891
Ġstudies 2.4226415
Ġto 1.0006613
Ġconfirm 2.5338316
Ġthe 1.1008186
Ġdrug 0.704896
's 0.00385481
Ġlong 2.2299087
- 0.014484947
term 0.004319361
Ġsafety 0.8402771
Ġand 0.18592463
Ġeffectiveness 2.4961276
. 0.11089593
Ċ 0.5844433
Reg 8.0660925
ulatory 0.04552435
Ġhurdles 2.1483614
Ġand 1.8346149
Ġpricing 3.3350265
Ġconcerns 1.0242039
: 0.08816545
Ċ 0.015801681
Moving 6.9115086
Ġforward 0.20334816
, 0.010418638
Ġregulatory 3.0819209
Ġapproval 0.97679865
Ġwill 1.4421996
Ġbe 0.48692495
Ġa 1.1369427
Ġcritical 1.8394678
Ġmilestone 2.12603
Ġfor 0.7360435
ĠT 1.5485244
um 0.001062851
oro 0.0015549365
C 0.0003506094
ure 0.0003626532
. 0.5954998
ĠAny 6.9181957
Ġdelays 2.4577239
Ġor 1.0317831
Ġshortcomings 5.102756
Ġin 0.60240775
Ġthe 0.95699054
Ġdrug 1.4813216
's 0.20678969
Ġapproval 1.0103577
Ġprocess 0.36059192
Ġmay 1.7109095
Ġsignificantly 2.0193295
Ġimpact 1.01791
Ġits 1.4162935
Ġmarket 1.0802525
Ġentry 3.3221948
Ġand 0.88497055
Ġultimate 4.062212
Ġsuccess 1.6425581
. 0.17134994
ĠAnaly 3.9861786
sts 0.00015148021
Ġalso 1.0306188
Ġraise 3.6055746
Ġconcerns 0.26928565
Ġover 0.8179114
Ġpotential 2.3556426
Ġpricing 0.084938444
Ġstrategies 3.4345329
, 0.897549
Ġas 1.7741567
Ġthe 1.1613264
Ġcosts 4.0858545
Ġassociated 1.6718324
Ġwith 0.007640128
Ġbi 7.028914
ote 3.4893203
chn 0.008088275
ological 0.0950665
Ġbreakthrough 5.2822485
s 0.0630019
Ġcan 2.202544
Ġbe 0.6650932
Ġconsiderable 3.9003382
. 0.36486197
ĠStri 8.913054
king 0.011621475
Ġa 0.6963883
Ġbalance 0.200305
Ġbetween 0.035175864
Ġaffordability 2.3352027
Ġfor 2.891251
Ġpatients 0.16788928
Ġand 0.08486804
Ġensuring 6.8863826
Ġa 1.5824593
Ġsustainable 2.7036526
Ġbusiness 0.8791452
Ġmodel 0.114952944
Ġfor 0.88516897
Ġthe 1.3374465
Ġcompany 0.64714146
Ġwill 0.44812965
Ġbe 0.19566453
Ġessential 2.3992856
Ġfor 1.3196287
Ġthe 1.1485182
Ġwidespread 4.3663135
Ġadoption 0.1792655
Ġof 0.10181349
Ġthis 3.5888503
Ġpotentially 3.216298
Ġlife 1.7544156
- 0.0061313156
saving 0.24155574
Ġdrug 0.8683788
. 0.016637243
Ċ 0.22919556
Comp 6.44976
etitive 1.2271646
Ġlandscape 0.225895
Ġand 1.6254799
Ġfuture 3.1655595
Ġdirections 6.5118246
: 0.07987083
Ċ 0.02437293
The 2.3986368
Ġcancer 3.9439414
Ġtherape 2.1780772
utics 7.24364e-05
Ġmarket 0.21172753
Ġis 0.29102913
Ġhighly 1.4378489
Ġcompetitive 0.39867038
, 0.37843502
Ġwith 0.36977333
Ġexisting 4.393886
Ġtreatment 2.7349026
Ġoptions 0.09956421
Ġalready 2.0979269
Ġapproved 5.0205994
Ġand 0.9848501
Ġin 2.2231975
Ġuse 0.6968764
. 0.47210556
ĠTo 4.208274
Ġpenetrate 4.7463555
Ġthis 1.121126
Ġmarket 1.0708551
, 0.34694254
ĠXY 0.9793854
Z 0.00020119963
Ġmust 2.3792953
Ġestablish 3.2325926
ĠT 1.3524394
um 0.00030070322
oro 0.001083796
C 0.00045442232
ure 0.0002704148
's 1.0664514
Ġsuperiority 2.5407107
Ġover 0.48573747
Ġestablished 3.8581822
Ġtherapies 1.2665963
. 1.765315
ĠFurthermore 3.7416425
, 0.00033940005
Ġit 3.9056306
Ġwill 1.2870747
Ġbe 0.7924188
Ġcrucial 2.03834
Ġto 0.8365481
Ġassess 5.0489383
Ġpotential 4.6179137
Ġsynerg 2.8224006
ies 0.06630008
Ġwith 0.8054092
Ġcomplementary 5.149668
Ġtreatments 2.0425851
Ġor 3.8116634
Ġdevelop 5.1810617
Ġcomb 8.517413
inational 0.6718159
Ġtherapies 0.59415156
Ġfor 2.496371
Ġimproved 3.6253352
Ġpatient 1.7526771
Ġoutcomes 0.09555214
. 0.1688333
ĠCollabor 7.362056
ations 0.6777027
Ġwith 0.30426058
Ġresearch 3.5528493
Ġbodies 6.0872374
, 2.1893237
Ġhealthcare 3.8456106
Ġinstitutions 2.5290875
, 0.06112209
Ġand 0.12000406
Ġpharmaceutical 1.6812289
Ġcompanies 0.20870021
Ġcould 2.8772569
Ġaccelerate 2.8924615
Ġthe 0.5738071
Ġdrug 0.6818089
's 0.122900054
Ġdevelopment 0.3703889
Ġand 0.4055438
Ġenhance 3.5499814
Ġits 0.2729972
Ġmarket 1.3491317
Ġpenetration 2.3975377
. 0.1395517
Ċ 0.4012683
Conclusion 3.958275
: 0.0531735
Ċ 0.050752837
British 5.2771196
Ġbiotech 4.075629
ĠXY 2.9961977
Z 0.0002801937
's 2.1310458
Ġcancer 1.7013824
Ġdrug 0.2910599
, 1.6699487
ĠT 0.1267937
um 0.0014225353
oro 0.0016706976
C 0.0015337429
ure 0.00038495276
, 0.030753197
Ġhas 0.57330465
Ġdisplayed 5.4272375
Ġencouraging 1.4776506
Ġresults 1.033577
Ġin 0.6404399
ĠPhase 1.3423594
ĠIII 0.015137855
Ġclinical 0.16839355
Ġtrials 0.01666664
, 1.1134729
Ġdemonstrating 1.8521451
Ġimpressive 5.0689964
Ġefficacy 0.3375499
Ġagainst 3.6163821
Ġvarious 1.7873017
Ġcancer 1.0642248
Ġtypes 0.029993713
Ġwith 3.7719312
Ġmanageable 4.495518
Ġside 0.15295584
Ġeffects 0.040777825
. 0.042087764
ĠHowever 1.2191651
, 0.00070580235
Ġanalysts 1.3192631
Ġurge 2.765842
Ġcaution 0.774787
, 1.5291766
Ġemphasizing 1.2545197
Ġthat 2.6146288
Ġfurther 1.6246667
Ġexploration 6.779066
, 3.5354848
Ġregulatory 6.614084
Ġapproval 0.36788005
, 0.032697428
Ġand 0.040731262
Ġadditional 3.1416545
Ġreal 4.9900036
- 0.008243914
world 0.02839515
Ġevidence 2.9956486
Ġare 0.9011198
Ġneeded 1.4846822
Ġbefore 1.110478
Ġwidespread 6.2406516
Ġimplementation 3.7286055
. 1.1181916
ĠOver 7.5143585
coming 0.8163427
Ġregulatory 3.619258
Ġhurdles 0.3460307
, 1.3132089
Ġpricing 1.203791
Ġchallenges 4.3657966
, 0.009087081
Ġand 0.047287587
Ġestablishing 2.4550815
Ġdifferentiation 6.002307
Ġfrom 0.7363632
Ġexisting 0.45401952
Ġtherapies 0.9704929
Ġwill 0.19815217
Ġdetermine 4.284251
Ġthe 0.32277444
Ġultimate 2.7905788
Ġsuccess 0.4327036
Ġof 0.11178525
ĠT 0.50407904
um 0.00020894819
oro 0.0005337355
C 0.001336586
ure 0.00021932404
. 0.6757564
ĠNevertheless 4.890268
, 0.00047809698
Ġthe 0.7308809
Ġinitial 4.4690742
Ġfindings 0.8113789
Ġoffer 3.3740313
Ġhope 1.6683792
Ġfor 0.5639135
Ġpatients 0.99822634
, 2.2120507
Ġpaving 4.5875573
Ġthe 0.030149605
Ġway 0.015581939
Ġfor 0.10430369
Ġpotential 3.6945293
Ġadvancements 3.578711
Ġin 0.044571873
Ġcancer 0.37995845
Ġtreatment 0.32634896
Ġand 2.3169787
Ġtransforming 7.964123
Ġthe 0.46452945
Ġlives 0.9313429
Ġof 0.006219299
Ġthose 1.8267639
Ġaffected 0.98502636
Ġby 0.30385748
Ġthe 0.9424175
Ġdisease 0.06862271
. 0.014494018
